Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 93,866 shares at $61.29 ($5.9M) on 2026-03-26, disclosed to the SEC on 2026-03-30.
Seasonal sale ($5.9M) by CHIEF EXECUTIVE OFFICER — this insider has traded WGS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.29 | 13,229 | $811K | 13.7% |
| 2 | $61.29 | 13,229 | $811K | 13.7% |
| 3 | $62.33 | 5,117 | $319K | 5.4% |
| 4 | $62.33 | 5,117 | $319K | 5.4% |
| 5 | $63.28 | 13,412 | $849K | 14.3% |
| 6 | $63.28 | 13,412 |
| $849K |
| 14.3% |
| 7 | $64.60 | 5,292 | $342K | 5.8% |
| 8 | $64.60 | 5,292 | $342K | 5.8% |
| 9 | $65.21 | 9,883 | $644K | 10.9% |
| 10 | $65.21 | 9,883 | $645K | 10.9% |
| Total | $63.17 avg | 93,866 | $5.9M | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |